Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies

There is a critical need to develop diagnostic procedures enabling early detection of tumors while at a curable stage. Technetium 99m ( 99m Tc)-labeled VQ peptide ( 99m Tc-HYNIC-VQ) identified through screening phage display peptide libraries against fresh human colonic adenomas was prepared and eva...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiyun Shi, Liyang Cui, Bing Jia, Zhaofei Liu, Peng He, Chengyan Dong, Xiaona Jin, Huiyun Zhao, Fang Li, Fan Wang
Format: Article
Language:English
Published: SAGE Publishing 2013-07-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2012.00047
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563115285643264
author Jiyun Shi
Liyang Cui
Bing Jia
Zhaofei Liu
Peng He
Chengyan Dong
Xiaona Jin
Huiyun Zhao
Fang Li
Fan Wang
author_facet Jiyun Shi
Liyang Cui
Bing Jia
Zhaofei Liu
Peng He
Chengyan Dong
Xiaona Jin
Huiyun Zhao
Fang Li
Fan Wang
author_sort Jiyun Shi
collection DOAJ
description There is a critical need to develop diagnostic procedures enabling early detection of tumors while at a curable stage. Technetium 99m ( 99m Tc)-labeled VQ peptide ( 99m Tc-HYNIC-VQ) identified through screening phage display peptide libraries against fresh human colonic adenomas was prepared and evaluated for tumor detection. 99m Tc-HYNIC-VQ was prepared by a non-SnCl 2 method with more than 99% radiochemical purity. The biodistribution in the HT-29 tumor model showed that although the absolute tumor uptake values were relatively low (0.60 ± 0.09, 0.41 ± 0.09, 0.36 ± 0.18, and 0.19 ± 0.08 %ID/g at 0.5, 1, 2, and 4 hours postinjection, respectively), the tumor uptake was higher than that of any of the other organs except for the kidneys at any time point examined, which led to the high tumor to nontarget ratios. The tumors and inflammation were clearly visualized with high contrast. Although the mechanism of accumulation of radiolabeled VQ peptide in tumors and inflammation needs to be further investigated, 99m Tc-HYNIC-VQ is a promising imaging agent for the early detection of tumors or premalignancies, at least for screening patients with a high risk of developing cancers.
format Article
id doaj-art-f135027d62c14091a0180537da77cf6b
institution Kabale University
issn 1536-0121
language English
publishDate 2013-07-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-f135027d62c14091a0180537da77cf6b2025-01-03T00:12:13ZengSAGE PublishingMolecular Imaging1536-01212013-07-011210.2310/7290.2012.0004710.2310_7290.2012.00047Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or PremalignanciesJiyun ShiLiyang CuiBing JiaZhaofei LiuPeng HeChengyan DongXiaona JinHuiyun ZhaoFang LiFan WangThere is a critical need to develop diagnostic procedures enabling early detection of tumors while at a curable stage. Technetium 99m ( 99m Tc)-labeled VQ peptide ( 99m Tc-HYNIC-VQ) identified through screening phage display peptide libraries against fresh human colonic adenomas was prepared and evaluated for tumor detection. 99m Tc-HYNIC-VQ was prepared by a non-SnCl 2 method with more than 99% radiochemical purity. The biodistribution in the HT-29 tumor model showed that although the absolute tumor uptake values were relatively low (0.60 ± 0.09, 0.41 ± 0.09, 0.36 ± 0.18, and 0.19 ± 0.08 %ID/g at 0.5, 1, 2, and 4 hours postinjection, respectively), the tumor uptake was higher than that of any of the other organs except for the kidneys at any time point examined, which led to the high tumor to nontarget ratios. The tumors and inflammation were clearly visualized with high contrast. Although the mechanism of accumulation of radiolabeled VQ peptide in tumors and inflammation needs to be further investigated, 99m Tc-HYNIC-VQ is a promising imaging agent for the early detection of tumors or premalignancies, at least for screening patients with a high risk of developing cancers.https://doi.org/10.2310/7290.2012.00047
spellingShingle Jiyun Shi
Liyang Cui
Bing Jia
Zhaofei Liu
Peng He
Chengyan Dong
Xiaona Jin
Huiyun Zhao
Fang Li
Fan Wang
Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
Molecular Imaging
title Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
title_full Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
title_fullStr Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
title_full_unstemmed Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
title_short Technetium 99m–Labeled VQ Peptide: A New Imaging Agent for the Early Detection of Tumors or Premalignancies
title_sort technetium 99m labeled vq peptide a new imaging agent for the early detection of tumors or premalignancies
url https://doi.org/10.2310/7290.2012.00047
work_keys_str_mv AT jiyunshi technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT liyangcui technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT bingjia technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT zhaofeiliu technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT penghe technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT chengyandong technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT xiaonajin technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT huiyunzhao technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT fangli technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies
AT fanwang technetium99mlabeledvqpeptideanewimagingagentfortheearlydetectionoftumorsorpremalignancies